Skip to main content
PMC home page
British Heart Journal logoLink to British Heart Journal
editorial
. 1994 Apr;71(4):307–308. doi: 10.1136/hrt.71.4.307

Who needs ventricular stimulation studies?

C J Garratt
PMCID: PMC483676  PMID: 8198877

Full text

PDF
307

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Coplen S. E., Antman E. M., Berlin J. A., Hewitt P., Chalmers T. C. Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized control trials. Circulation. 1990 Oct;82(4):1106–1116. doi: 10.1161/01.cir.82.4.1106. [DOI] [PubMed] [Google Scholar]
  2. Farrell T. G., Bashir Y., Cripps T., Malik M., Poloniecki J., Bennett E. D., Ward D. E., Camm A. J. Risk stratification for arrhythmic events in postinfarction patients based on heart rate variability, ambulatory electrocardiographic variables and the signal-averaged electrocardiogram. J Am Coll Cardiol. 1991 Sep;18(3):687–697. doi: 10.1016/0735-1097(91)90791-7. [DOI] [PubMed] [Google Scholar]
  3. Fogoros R. N. The effect of the implantable cardioverter defibrillator on sudden death and on total survival. Pacing Clin Electrophysiol. 1993 Mar;16(3 Pt 2):506–510. doi: 10.1111/j.1540-8159.1993.tb01617.x. [DOI] [PubMed] [Google Scholar]
  4. Fromer M., Shenasa M. A critical reappraisal of serial electrophysiologic drug testing for sustained ventricular tachycardia. Am Heart J. 1987 Dec;114(6):1537–1541. doi: 10.1016/0002-8703(87)90582-5. [DOI] [PubMed] [Google Scholar]
  5. Kadish A. H., Buxton A. E., Waxman H. L., Flores B., Josephson M. E., Marchlinski F. E. Usefulness of electrophysiologic study to determine the clinical tolerance of arrhythmia recurrences during amiodarone therapy. J Am Coll Cardiol. 1987 Jul;10(1):90–96. doi: 10.1016/s0735-1097(87)80165-1. [DOI] [PubMed] [Google Scholar]
  6. Kuchar D. L., Rottman J., Berger E., Freeman C. S., Garan H., Ruskin J. N. Prediction of successful suppression of sustained ventricular tachyarrhythmias by serial drug testing from data derived at the initial electrophysiologic study. J Am Coll Cardiol. 1988 Oct;12(4):982–988. doi: 10.1016/0735-1097(88)90465-2. [DOI] [PubMed] [Google Scholar]
  7. Mason J. W. A comparison of electrophysiologic testing with Holter monitoring to predict antiarrhythmic-drug efficacy for ventricular tachyarrhythmias. Electrophysiologic Study versus Electrocardiographic Monitoring Investigators. N Engl J Med. 1993 Aug 12;329(7):445–451. doi: 10.1056/NEJM199308123290701. [DOI] [PubMed] [Google Scholar]
  8. Mason J. W. A comparison of seven antiarrhythmic drugs in patients with ventricular tachyarrhythmias. Electrophysiologic Study versus Electrocardiographic Monitoring Investigators. N Engl J Med. 1993 Aug 12;329(7):452–458. doi: 10.1056/NEJM199308123290702. [DOI] [PubMed] [Google Scholar]
  9. Powell A. C., Fuchs T., Finkelstein D. M., Garan H., Cannom D. S., McGovern B. A., Kelly E., Vlahakes G. J., Torchiana D. F., Ruskin J. N. Influence of implantable cardioverter-defibrillators on the long-term prognosis of survivors of out-of-hospital cardiac arrest. Circulation. 1993 Sep;88(3):1083–1092. doi: 10.1161/01.cir.88.3.1083. [DOI] [PubMed] [Google Scholar]
  10. Ruskin J. N., DiMarco J. P., Garan H. Out-of-hospital cardiac arrest: electrophysiologic observations and selection of long-term antiarrhythmic therapy. N Engl J Med. 1980 Sep 11;303(11):607–613. doi: 10.1056/NEJM198009113031103. [DOI] [PubMed] [Google Scholar]
  11. Saksena S., Camm A. J. Implantable defibrillators for prevention of sudden death. Technology at a medical and economic crossroad. Circulation. 1992 Jun;85(6):2316–2321. doi: 10.1161/01.cir.85.6.2316. [DOI] [PubMed] [Google Scholar]
  12. Steinbeck G., Andresen D., Bach P., Haberl R., Oeff M., Hoffmann E., von Leitner E. R. A comparison of electrophysiologically guided antiarrhythmic drug therapy with beta-blocker therapy in patients with symptomatic, sustained ventricular tachyarrhythmias. N Engl J Med. 1992 Oct 1;327(14):987–992. doi: 10.1056/NEJM199210013271404. [DOI] [PubMed] [Google Scholar]
  13. Swerdlow C. D., Winkle R. A., Mason J. W. Determinants of survival in patients with ventricular tachyarrhythmias. N Engl J Med. 1983 Jun 16;308(24):1436–1442. doi: 10.1056/NEJM198306163082402. [DOI] [PubMed] [Google Scholar]
  14. Waller T. J., Kay H. R., Spielman S. R., Kutalek S. P., Greenspan A. M., Horowitz L. N. Reduction in sudden death and total mortality by antiarrhythmic therapy evaluated by electrophysiologic drug testing: criteria of efficacy in patients with sustained ventricular tachyarrhythmia. J Am Coll Cardiol. 1987 Jul;10(1):83–89. doi: 10.1016/s0735-1097(87)80164-x. [DOI] [PubMed] [Google Scholar]
  15. Wilber D. J., Garan H., Finkelstein D., Kelly E., Newell J., McGovern B., Ruskin J. N. Out-of-hospital cardiac arrest. Use of electrophysiologic testing in the prediction of long-term outcome. N Engl J Med. 1988 Jan 7;318(1):19–24. doi: 10.1056/NEJM198801073180105. [DOI] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES